– UK, London – British American Tobacco p.l.c. (LON: BATS) announced the appointment of Uta Kemmerich-Keil to its Board as an Independent Non-Executive Director effective from 17 February 2025.
“I am pleased to welcome Uta Kemmerich-Keil to our Board. Her strong general management background in regulated industries, combined with her experience in consumer, digital and strategic transformation will be beneficial as BAT continues on its ambition to build a Smokeless World”, said Board Chair, Luc Jobin.
The company also announced that Murray Kessler will step down from the Board on 17 February 2025.
Uta Kemmerich-Keil will also join the Audit and Nominations Committees.
About Uta Kemmerich-Keil
Uta Kemmerich-Keil previously held the role of CEO of Personal Healthcare International at P&G from 2018 to 2020, and before that spent 19 years at Merck Group where she held several roles including CEO of Consumer Health Division, CEO of Allegropharma and Global Business Unit Head, Allergy as well as Head of Corporate M&A, Treasury, and Finance. Before joining Merck Group, she was a Senior Financial Auditor at Hoechst AG. Uta currently serves as a member of the Supervisory Board and Chair of the Audit Committee at Beiersdorf.
For more: https://www.bat.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.